# The Role of Secondary Bile Acids in Intestinal Inflammation

> **NCT03724175** · PHASE2,PHASE3 · TERMINATED · sponsor: **Stanford University** · enrollment: 2 (actual)

## Conditions studied

- Ulcerative Colitis
- Pouchitis

## Interventions

- **DRUG:** ursodiol (ursodeoxycholic acid, UDCA)

## Key facts

- **NCT ID:** NCT03724175
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-08-26
- **Primary completion:** 2026-03-02
- **Final completion:** 2026-03-02
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Lack of recruitment and funding.
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03724175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03724175, "The Role of Secondary Bile Acids in Intestinal Inflammation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03724175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*